289 Current news from the ressort products
rss |
You can refine your search further. Select from the filter options on the left to narrow down your results. |
Life-science startup Actome announces release of first commercial products
09-May-2022
Actome has released the first commercial products to the EU market based on the Protein Interaction Coupling (PICO) Technology. The PICO assay kits for measuring proteins and protein interactions are available throughActome's online webshop. Actome GmbH is a life-science startup form Freiburg ...
In-vitro-Diagnostic company Spindiag, a University of Freiburg and Hahn-Schickard spin-off, has been recognized for its research-based development
19-Apr-2022
Spindiag GmbH, together with the University of Freiburg and the Hahn-Schickard-Gesellschaft für angewandte Forschung e.V., was awarded the Technology Transfer Prize 2020 from the German Physical Society (DPG) on April 09, 2022 for the development of the PCR-based rapid test system Rhonda. The ...
NanoTemper Technologies and PharmAI launch Proto
12-Apr-2022
NanoTemper Technologies, in partnership with PharmAI, announced the launch of Proto, a free AI-based web application that reveals the best labeling strategy to help scientists more efficiently measure molecular interactions, a process that’s necessary to discover and develop new drugs. Proto is ...
Startup trinamiX expands NIR spectroscopy portfolio by transmission solution
10-Nov-2021
trinamiX GmbH, a wholly owned subsidiary of BASF SE, is presenting the latest addition to their pioneering portfolio: A portable solution to grant institutions and companies immediate insights into the molecular composition of liquids. trinamiX has once more successfully transformed the ...
Detection with independently taken samples can work
12-Aug-2021
A large proportion of women who develop cervical cancer in high-income countries such as Germany do not regularly attend screening. This is particularly alarming, as cancer screenings have become much less frequent since the onset of the corona pandemic. A study by Hannover Medical School and the ...
"This is pretty cool but also scary and hopefully somewhat useful"
21-Jun-2021
Scientists from deCODE genetics have developed a predictor based on protein measurements in blood samples that predicts the time to all-cause death better than traditional risk factors. In a paper published in Communications Biology, scientists from deCODE genetics,a subsidiary of Amgen, ...
"SweepMe!" simplifies the use of measuring devices
28-Apr-2021
In order to control it, different libraries, protocols and command sets need to be followed. If you ever have to combine several devices from different manufacturers, you virtually have to take an additional course in computer science. This is because, in each case, a separate software is ...
Drug Screening with 3D Cell Cultures
24-Mar-2021
On the basis of a license agreement with the German Center for Neurodegenerative Diseases (DZNE) and the Leibniz Institute of Polymer Research Dresden (IPF), the Dresden-based start-up “Neuron-D GmbH” is developing a high-throughput system for testing drug candidates to treat neurodegenerative ...
01-Feb-2021
The central German start-up company "nanozoo" – a member of the InfectoGnostics research campus in Jena – has launched a portal for the free analysis and processing of raw data from the genome sequencing of SARS-CoV-2 isolates. Within a few hours, the data of registered users will be processed ...
Mutations can be assigned directly without any intermediate mathematical steps
18-Jan-2021
The rapid spread of the newly emerging SARS-CoV-2 virus variant B.1.1.7 in Great Britain and other countries shows, changes in the genome of the SARS-CoV-2 virus can lead to new biological properties. Most of the approximately 12,000 mutations in the genome of the SARS-CoV-2 virus that have been ...
